NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
基本信息
- 批准号:10711136
- 负责人:
- 金额:$ 33.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAccelerationAccountingAddressAdultAffectAnxiety DisordersApplications GrantsArkansasBehaviorBehavior assessmentBusinessesCellsCitiesCommon CoreCommon Data ElementDSM-VDataData AnalysesData CollectionDatabasesDevelopmentDiagnosisDiagnosticDiseaseEquilibriumExtramural ActivitiesFee-for-Service PlansFormulationFutureGoalsGuidelinesHealth SciencesIndividualInfrastructureInstitutionInteroceptionInterviewLeadershipLiteratureMeasuresMental HealthMental disordersMood DisordersMoodsMotivationNational Institute of Mental HealthNegative ValenceNeurosciencesNeurosciences ResearchOklahomaParticipantPatient RecruitmentsPatient Self-ReportPerformancePhasePhenX ToolkitPhysiologyPilot ProjectsPositive ValenceProceduresProcessReproducibilityResearchResearch Domain CriteriaResearch PersonnelResearch Project GrantsResearch SupportResourcesSeveritiesSignal TransductionStandardizationStimulusStructureSymptomsSystemTeenagersThinkingTrainingUnited States National Institutes of HealthUniversitiesUpdateValidationWorkapproach behavioravoidance behaviorbasehealth assessmentinstrumentmeetingsmotivated behaviornegative affectnoveloperationrecruitresearch studyresponsescreening
项目摘要
PROJECT SUMMARY: Recruitment and Assessment Core
Psychiatric research relies on the use of validated and reliable self-report, interview-based, and behavioral
assessments to diagnose DSM-5 psychiatric disorders, estimate level of severity of mental health symptoms,
and to delineate transdiagnostic constructs of relevance across disorders. The Recruitment and Assessment
Core of the Center for Neuroscience-based Mental Health Assessment and Prediction (NeuroMAP) in Phase
II will support Research Project Leaders (RPLs) and Pilot Project Investigators (PPIs) by overseeing and
completing the recruitment, screening, and common Core interview-based, self-report, and behavioral
assessment procedures. The goal of the Recruitment and Assessment Core is to accelerate the RPL and
PPI projects by allowing for efficient participant recruitment and more rapid data collection, aiding in the
formulation of aims and hypotheses based on core data, and thereby making R-level grant applications more
competitive. The Recruitment and Assessment Core will work closely with the Circuits and Molecules Core
to support a multi-level assessment approach (symptoms & behavior, circuits & physiology, cells &
molecules) and is structured to support the NeuroMAP theme: identification and validation, via an
experimental approach, of targetable disease-modifying processes (DMPs) in mood and anxiety disorders.
During Phase I, common data elements were established across all RPL projects and provided a balance
between the research goals of the individual RPL projects and secondary data analyses for PPIs. During this
phase, the Core was able to recruit 552 participants for RPLs and each project reached recruitment
milestones despite SARS-CoV-2 and a two-month shutdown of the institute. Moreover, 8 PPI used the Core
data to identify novel DMPs in mood and anxiety disorders. The Core focuses on measures derived from a
modified NIMH Research Domain Criteria approach: (a) Negative Valence Systems measures, i.e., how
individuals respond to aversive situations or context (RPL Project 1 focuses on threat sensitivity; Project 2
focuses on avoidance behavior, Project 3 focuses on repetitive negative thinking); (b) Positive Valence
Systems measures, i.e., how individuals respond to positive motivational situations or contexts (Project 2 will
focus on approach motivation); (c) Interoception measures, i.e. sensing, processing, and integrating internal
bodily signals together with external stimuli to affect motivated behavior (Project 2 focuses on responses to
interoceptive perturbation). The aims of the core are (1) to provide timely recruitment and standardized
assessments for all NeuroMAP projects; (2) to maintain a reproducible and reliable assessment structure
that can be used for extramurally supported projects; and (3) to develop a self-sustainable business plan for
the user base. The Core will be a unique resource for LIBR investigators as well as researchers at other
academic institutions in northeastern Oklahoma and Arkansas.
项目摘要:招聘和评估核心
精神病学研究依赖于使用经过验证和可靠的自我报告、访谈和行为
诊断 DSM-5 精神疾病的评估,估计精神健康症状的严重程度,
并描述跨疾病相关的跨诊断结构。招聘与考核
基于神经科学的心理健康评估和预测中心(NeuroMAP)的核心阶段
II 将通过监督和支持研究项目负责人 (RPL) 和试点项目研究者 (PPI)
完成招聘、筛选和共同核心面试、自我报告和行为
评估程序。招聘和评估核心的目标是加速 RPL 和
PPI 项目通过允许高效的参与者招募和更快速的数据收集来帮助
基于核心数据制定目标和假设,从而使R级资助申请更加容易
竞争的。招募和评估核心将与电路和分子核心密切合作
支持多层次评估方法(症状和行为、回路和生理学、细胞和
分子),其结构支持 NeuroMAP 主题:识别和验证,通过
情绪和焦虑症的有针对性的疾病缓解过程(DMP)的实验方法。
在第一阶段,所有 RPL 项目都建立了通用数据元素,并提供了平衡
各个 RPL 项目的研究目标和 PPI 的二次数据分析之间的关系。在此期间
阶段,核心能够招募 552 名 RPL 参与者,每个项目都达到招募人数
尽管出现 SARS-CoV-2 且该研究所关闭了两个月,但仍取得了里程碑式的进展。此外,8 PPI 使用了 Core
识别情绪和焦虑障碍的新型 DMP 的数据。核心重点关注源自以下方面的措施:
修改后的 NIMH 研究领域标准方法:(a) 负价系统测量,即如何
个人对厌恶的情况或环境做出反应(RPL 项目 1 侧重于威胁敏感性;项目 2
重点关注回避行为,项目3重点关注重复性消极思维); (b) 正价
系统测量,即个人如何应对积极的动机情况或环境(项目 2 将
关注方法动机); (c) 内感知措施,即感知、处理和整合内部信息
身体信号与外部刺激一起影响动机行为(项目 2 侧重于对
内感受扰动)。核心目标是(1)提供及时的招聘和标准化
所有 NeuroMAP 项目的评估; (2) 保持可重复且可靠的评估结构
可用于外部支持的项目; (3) 制定自我可持续的商业计划
用户群。该核心将成为 LIBR 研究人员以及其他研究人员的独特资源
俄克拉荷马州东北部和阿肯色州的学术机构。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBIN L AUPPERLE其他文献
ROBIN L AUPPERLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBIN L AUPPERLE', 18)}}的其他基金
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 33.99万 - 项目类别:
15/21 ABCD-USA Consortium: Research Project Site at LIBR
15/21 ABCD-美国联盟:LIBR 研究项目现场
- 批准号:
9980594 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
15/21 ABCD-USA Consortium: Research Project Site at LIBR
15/21 ABCD-美国联盟:LIBR 研究项目现场
- 批准号:
10595541 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
15/21 ABCD-USA Consortium: Research Project Site at LIBR
15/21 ABCD-美国联盟:LIBR 研究项目现场
- 批准号:
10379336 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
An Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome in Anxiety and Depression
预测焦虑和抑郁行为治疗结果的避免接近计算框架
- 批准号:
10651737 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
An Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome in Anxiety and Depression
预测焦虑和抑郁行为治疗结果的避免接近计算框架
- 批准号:
10199995 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
An Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome in Anxiety and Depression
预测焦虑和抑郁行为治疗结果的避免接近计算框架
- 批准号:
10029376 - 财政年份:2020
- 资助金额:
$ 33.99万 - 项目类别:
Approach-Avoidance Conflict-a multi-level predictor for exposure therapy response
接近-回避冲突——暴露疗法反应的多级预测因子
- 批准号:
9260939 - 财政年份:2016
- 资助金额:
$ 33.99万 - 项目类别:
Approach-Avoidance Conflict-a multi-level predictor for exposure therapy response
接近-回避冲突——暴露疗法反应的多级预测因子
- 批准号:
9109386 - 财政年份:2016
- 资助金额:
$ 33.99万 - 项目类别:
相似国自然基金
面向电力储能集群系统的加速退化试验与寿命评估方法研究
- 批准号:62303293
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向计算密集型应用的新型计算范式及其加速器关键技术
- 批准号:62374108
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于任意精度计算架构的量子信息处理算法硬件加速技术研究
- 批准号:62304037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
分布式非凸非光滑优化问题的凸松弛及高低阶加速算法研究
- 批准号:12371308
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
极端光场条件下正电子束的产生、加速和操控研究
- 批准号:12375244
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
指导非小细胞肺癌放疗使用的生物标志物驱动策略
- 批准号:
10518064 - 财政年份:2023
- 资助金额:
$ 33.99万 - 项目类别:
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711001 - 财政年份:2023
- 资助金额:
$ 33.99万 - 项目类别:
Mentoring the next generation of substance use, HIV, and epigenetic researchers in sexual and gender minority health
指导下一代性和性别少数健康领域的药物滥用、艾滋病毒和表观遗传学研究人员
- 批准号:
10699933 - 财政年份:2023
- 资助金额:
$ 33.99万 - 项目类别:
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
为 MedStar Health 接受肺癌筛查的患者提供烟草治疗:一项随机试验
- 批准号:
10654115 - 财政年份:2023
- 资助金额:
$ 33.99万 - 项目类别:
Sensitivity to Cannabis Effects and Cue Reactivity as Markers of a Developing Disorder in Adolescents
对大麻效应的敏感性和提示反应性作为青少年发育障碍的标志
- 批准号:
10586397 - 财政年份:2023
- 资助金额:
$ 33.99万 - 项目类别: